Affiliation:
1. Center for Natural and Human Sciences Federal University of ABC 09210-580 Santo Andre, SP Brazil
2. Butantan Institute, 1500 05503-900 São Paulo, SP Brazil
3. Department of Agricultural and Biological Sciences Federal University of Espirito Santo 29932-540 São Matheus, ES Brazil
Abstract
AbstractAs part of our continuous research for the discovery of bioactive compounds against Trypanosoma cruzi and Leishmania infantum, the alkaloid (6aS)‐dicentrine (1) was oxidized to afford (6aS,6S)‐ (2) and (6aS,6R)‐ (3) dicentrine‐N‐oxides. Evaluation of the cytotoxicity against NCTC cells indicated that 2 and 3 are non‐toxic (CC50>200 μM) whereas 1 demonstrated CC50 of 52.0 μM. Concerning T. cruzi activity against amastigotes, derivatives 2 and 3 exhibited EC50 values of 9.9 μM (SI>20.2) and 27.5 μM (SI>7.3), respectively, but 1 is inactive (EC50>100 μM). Otherwise, when tested against L. infantum amastigotes, 1 and 3 exhibited EC50 values of 10.3 μM (SI=5.0) and 12.7 μM (SI>15.7), respectively, being 2 inactive (EC50>100 μM). Comparing the effects of positive controls benznidazol (EC50=6.5 μM and SI>30.7) and miltefosine (EC50=10.2 μM and SI=15.2), it was observed a selective antiparasitic activity to diastereomers 2 and 3 against T. cruzi and L. infantum. Considering stereochemical aspects, it was suggested that the configuration of the new stereocenter formed after oxidation of 1 played an important role in the bioactivity against amastigotes of both tested parasites.
Funder
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Fundação de Amparo à Pesquisa do Estado de São Paulo